Athersys (ATHX) MultiStem Granted Orphan Drug Designation by FDA for Hurler's Syndrome Treatment
Go back to Athersys (ATHX) MultiStem Granted Orphan Drug Designation by FDA for Hurler's Syndrome Treatment| Athersys, Inc. (NASDAQ: ATHX) | Delayed: 0.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.10 | 52 Week High | $2.90 | |||
| Open | $2.42 | 52 Week Low | $0.97 | |||
| Day High | $0.10 | P/E | N/A | |||
| Day Low | $0.10 | EPS | $-0.45 | |||
| Volume | 35,513 | |||||
